Main > ONCOLOGY (**) > Skin Cancer>Melanoma>MET *** > Treatment > Co: USA. B. IpilimuMAb. ***

---

Co: USA. B. IpilimuMAb. ***'s subsections
(*) EU Approval Date: 2011. 07.12.>
(*) USA Approval Date: 2011. 03>
(*) USA Approval Date: 2015. 10.28>
Anti-CTLA-4 MAb
Company
Patent>Assignee; Claims; No.; Etc.
TradeMark
TradeMark Web-Site

Co: USA. B. IpilimuMAb. ***'s products
This section has no products